Fibrotic disease and the TH1/TH2 paradigm
Open accessThe DOI matches its Crossref record; 137 of the 137 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Similarly, interferon-γ (IFNγ), produced by many immune cells including NK, NKT and T cells, has direct anti-fibrogenic activity on HSCs (70–72).”
From Hepatic Stellate Cell-Immune Interactions in NASH (2022) · cites this paper as [71]
Experimental — accuracy not yet measuredIn the citing paper
“Recent evidence indicates that myofibroblast-induced fibrosis can be over-activated, not only in the setting of signaling through TGF-β, but also in the setting of Th2-derived cytokines IL-4 and IL-13; Th1 cytokines, such as IFN-γ, attenuate excessive scar formation [100, 101].”
From Immunology of Wound Healing (2018) · cites this paper as [100]
In the citing paper
“Recent evidence indicates that myofibroblast-induced fibrosis can be over-activated, not only in the setting of signaling through TGF-β, but also in the setting of Th2-derived cytokines IL-4 and IL-13; Th1 cytokines, such as IFN-γ, attenuate excessive scar formation [100, 101].”
From Immunology of Wound Healing (2018) · cites this paper as [100]
In the citing paper
“Recent evidence indicates that myofibroblast-induced fibrosis can be over-activated, not only in the setting of signaling through TGF-β, but also in the setting of Th2-derived cytokines IL-4 and IL-13; Th1 cytokines, such as IFN-γ, attenuate excessive scar formation [100, 101].”
From Immunology of Wound Healing (2018) · cites this paper as [100]
In the citing paper
“Normally, myofibroblasts carefully coordinate the breakdown of granulation tissue and replacement with long-lasting type I collagen [100].”
From Immunology of Wound Healing (2018) · cites this paper as [100]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Interleukin-10 and the Interleukin-10 Receptor
Moore, K. W., de Waal Malefyt, R., Coffman, R. L., & O'Garra, A. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.683 · Cited by 6,737 · cited 1×
“However, it is now described as a general immunosuppressive cytokine that downregulates chronic inflammatory responses through many mechanism”
BackgroundAlternative activation of macrophages
Gordon, S. (2003) · Nature Reviews Immunology · doi:10.1038/nri978 · Cited by 6,189
(1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-92-3-460_4 · Cited by 4,529
Functional diversity of helper T lymphocytes
Abbas, A. K., Murphy, K. M., & Sher, A. (1996) · Nature · doi:10.1038/383787a0 · Cited by 4,450
Interleukin-13: Central Mediator of Allergic Asthma
Wills-Karp, M., Luyimbazi, J., Xu, X., Schofield, B., Neben, T. Y., Karp, C. L., & Donaldson, D. D. (1998) · Science · doi:10.1126/science.282.5397.2258 · Cited by 2,617
Munger, J. S., Huang, X., Kawakatsu, H., Griffiths, M. J. D., Dalton, S. L., Wu, J., Pittet, J.-F., Kaminski, N., Garat, C., Matthay, M. A., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80545-0 · Cited by 2,076
Kulkarni, A. B., Huh, C. G., Becker, D., Geiser, A., Lyght, M., Flanders, K. C., Roberts, A. B., Sporn, M. B., Ward, J. M., & Karlsson, S. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.2.770 · Cited by 1,967
REGULATION OF IMMUNE RESPONSES BY TGF-β
Letterio, J. J., & Roberts, A. B. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.137 · Cited by 1,890
Requirement for IL-13 Independently of IL-4 in Experimental Asthma
Grünig, G., Warnock, M., Wakil, A. E., Venkayya, R., Brombacher, F., Rennick, D. M., Sheppard, D., Mohrs, M., Donaldson, D. D., Locksley, R. M., et al. (1998) · Science · doi:10.1126/science.282.5397.2261 · Cited by 1,849
Zhu, Z., Homer, R. J., Wang, Z., Chen, Q., Geba, G. P., Wang, J., Zhang, Y., & Elias, J. A. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5909 · Cited by 1,719
Cited by
Items 401–500 of 1,000
Greenblatt, M. B., Sargent, J. L., Farina, G. A., Tsang, K., Lafyatis, R., Glimcher, L. H., Whitfield, M. L., & Aliprantis, A. O. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.11.024 · Cited by 84
Li, Y., Wu, Y., Zhang, C., Li, P., Cui, W., Hao, J., Ma, X., Yin, Z., & Du, J. (2014) · Hypertension · doi:10.1161/hypertensionaha.113.02604 · Cited by 87
Molnar, V., Pavelić, E., Vrdoljak, K., Čemerin, M., Klarić, E., Matišić, V., Bjelica, R., Brlek, P., Kovačić, I., Tremolada, C., et al. (2022) · Genes · doi:10.3390/genes13060949 · Cited by 90
“This dysfunctional tissue architecture is characterized by excessive accumulation of extracellular matrix components, such as the collagen produced by fibroblasts [70].”
BackgroundType 2 Immune Mechanisms in Carbon Nanotube-Induced Lung Fibrosis
Dong, J., & Ma, Q. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01120 · Cited by 83
Hepatic Stellate Cell-Immune Interactions in NASH
Carter, J. K., & Friedman, S. L. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.867940 · Cited by 79
Stoermer, K. A., Burrack, A., Oko, L., Montgomery, S. A., Borst, L. B., Gill, R. G., & Morrison, T. E. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201240 · Cited by 79
Cui, H. S., Hong, A. R., Kim, J., Yu, J. H., Cho, Y. A., Joo, S. Y., & Seo, C. H. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19010124 · Cited by 88
Torok, K. S., Kurzinski, K. L., Zigler, C. K., Yabes, J. G., Magee, K. E., Vallejo, A. N., Medsger, T. A., & Feghali‐Bostwick, C. A. (2015) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2015.06.006 · Cited by 79
Olsan, E. E., Mukherjee, S., Wulkersdorfer, B., Shillingford, J. M., Giovannone, A. J., Todorov, G., Song, X., Pei, Y., & Weimbs, T. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1111966108 · Cited by 80
Marquart, S., Zerr, P., Akhmetshina, A., Palumbo, K., Reich, N., Tomčík, M., Horn, A., Dees, C., Engel, M., Zwerina, J., et al. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27642 · Cited by 94
From phagocyte diversity and activation to probiotics: Back to Metchnikoff
Mantovani, A. (2008) · European Journal of Immunology · doi:10.1002/eji.200838918 · Cited by 78
Stem cell therapy for idiopathic pulmonary fibrosis: a protocol proposal
Τzouvelekis, Α., Koliakos, G., Ntolios, P., Baira, I., Bouros, E., Oikonomou, A., Zissimopoulos, A., Kolios, G. C., Kakagia, D. D., Paspaliaris, V., et al. (2011) · Journal of Translational Medicine · doi:10.1186/1479-5876-9-182 · Cited by 87
Zhu, Z., Ding, J., Ma, Z., Iwashina, T., & Tredget, E. E. (2017) · Wound Repair and Regeneration · doi:10.1111/wrr.12532 · Cited by 78
B cells in systemic sclerosis: A possible target for therapy
Bosello, S. L., Luca, G. D. D., Tolusso, B., Lama, G., Angelucci, C., Sica, G., & Ferraccioli, G. (2011) · Autoimmunity Reviews · doi:10.1016/j.autrev.2011.04.013 · Cited by 77
Bashoura, L., Gupta, S., Jain, A., Couriel, D. R., Komanduri, K. V., Eapen, G. A., Safdar, A., Broglio, K., Adachi, R., & Dickey, B. F. (2007) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1705877 · Cited by 76
Scar and Contracture: Biological Principles
Kwan, P. O., Hori, K., Ding, J., & Tredget, E. E. (2009) · Hand Clinics · doi:10.1016/j.hcl.2009.06.007 · Cited by 85
Paulín, F., Doyle, T. J., Fletcher, E. A., Ascherman, D. P., & Rosas, I. O. (2015) · Revista de investigaci�n Cl�nica · doi:10.1016/s0034-8376(25)00249-9 · Cited by 94
Santoni, G., Morelli, M. B., Amantini, C., Santoni, M., Nabissi, M., Marinelli, O., & Santoni, A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01273 · Cited by 77
Chunn, J. L., Mohsenin, A., Young, H. W. J., Lee, C. G., Elias, J. A., Kellems, R. E., & Blackburn, M. R. (2005) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00258.2005 · Cited by 82
Idiopathic pulmonary fibrosis (IPF) signaling pathways and protective roles of melatonin
Hosseinzadeh, A., Javad-Moosavi, S. A., Reiter, R. J., Hemati, K., Ghaznavi, H., & Mehrzadi, S. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.03.032 · Cited by 77
Fibroblast activation and heterogeneity in fibrotic disease
Zhang, X., Zhang, Y., & Liu, Y. (2025) · Nature Reviews Nephrology · doi:10.1038/s41581-025-00969-8 · Cited by 101
T cells in idiopathic pulmonary fibrosis: crucial but controversial
Deng, L., Huang, T., & Zhang, L. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01344-x · Cited by 74
Cellular/extracellular matrix cross‐talk in scar evolution and control
Widgerow, A. D. (2011) · Wound Repair and Regeneration · doi:10.1111/j.1524-475x.2010.00662.x · Cited by 85
Costs of reproduction in a long-lived female primate: injury risk and wound healing
Archie, E. A., Altmann, J., & Alberts, S. C. (2014) · Behavioral Ecology and Sociobiology · doi:10.1007/s00265-014-1729-4 · Cited by 82
“Indeed, efficient wound healing draws on several immune components, including inflammatory responses, cell-mediated aspects of innate immunity, and some Th2-mediated processes (Martin 1997; Singer and Clark 1999; Wynn 2004; Seno et al. 2009).”
IL-11 Receptor α in the Pathogenesis of IL-13-Induced Inflammation and Remodeling
Chen, Q., Rabach, L., Noble, P., Zheng, T., Lee, C. G., Homer, R. J., & Elias, J. A. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.4.2305 · Cited by 74
Collagen constitutes about 12% in females and 17% in males of the total protein in mice
Tarnutzer, K., Sankar, D. S., Dengjel, J., & Ewald, C. Y. (2023) · Scientific Reports · doi:10.1038/s41598-023-31566-z · Cited by 94
The Pathogenesis of Systemic Sclerosis Revisited
Geyer, M., & Müller‐Ladner, U. (2010) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-009-8193-3 · Cited by 79
“The cytokines IL-4 and IL-13 also exhibit important roles in the pathogenesis of profibrotic and TH2 cellmediated disorders [61].”
BackgroundNikota, J. K., Williams, A., Yauk, C. L., Wallin, H., Vogel, U. B., & Halappanavar, S. S. (2015) · Particle and Fibre Toxicology · doi:10.1186/s12989-016-0137-5 · Cited by 76
“The lung injury models including bleomycin, Th2 response-mediated allergy, and bacterial infection are all known to cause lung fibrosis [27].”
BackgroundResultLee, J.-U., Chang, H. S., Lee, H. J., Jung, C. A., Bae, D. J., Song, H. J., Park, J. S., Uh, S.-T., Kim, Y. H., Seo, K.-H., et al. (2017) · BMC Pulmonary Medicine · doi:10.1186/s12890-017-0380-z · Cited by 73
Yang, Y., Wu, X.-Q., Li, W.-X., Huang, H.-M., Li, H.-D., Pan, X.-Y., Li, X.-F., Huang, C., Meng, X.-M., Zhang, L., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0383-0 · Cited by 72
Interactive effects of cerium oxide and diesel exhaust nanoparticles on inducing pulmonary fibrosis
Ma, J. Y. C., Young, S.-H., Mercer, R. R., Barger, M., Schwegler-Berry, D., Ma, J. K., & Castranova, V. (2014) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2014.04.019 · Cited by 72
“Studies have shown that Th2 cytokines promote the differentiation of profibrogenic macrophages and the development of fibrotic diseases (Wynn, 2004).”
BackgroundNon‐invasive biomarkers in pulmonary fibrosis
Prasse, A., & Müller–Quernheim, J. (2009) · Respirology · doi:10.1111/j.1440-1843.2009.01600.x · Cited by 80
Aberrant histone modification in peripheral blood B cells from patients with systemic sclerosis
Wang, Y., Yang, Y., Luo, Y., Yin, Y., Wang, Q., Li, Y., Kanekura, T., Wang, J., Liang, G., Zhao, M., et al. (2013) · Clinical Immunology · doi:10.1016/j.clim.2013.06.006 · Cited by 73
Galectin-3: its role in asthma and potential as an anti-inflammatory target
Gao, P., Simpson, J. L., Zhang, J., & Gibson, P. G. (2013) · Respiratory Research · doi:10.1186/1465-9921-14-136 · Cited by 82
An update on animal models of liver fibrosis
Wu, S., Wang, X., Xing, W., Li, F., Liang, M., Li, K., He, Y., & Wang, J. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1160053 · Cited by 71
“Organ fibrosis is the characteristic of the progression of chronic inflammatory diseases, which account for 45% of global all-cause mortality (1).”
BackgroundRole of interleukin‐13 in fibrosis, particularly systemic sclerosis
O’Reilly, S. (2013) · BioFactors · doi:10.1002/biof.1117 · Cited by 71
“It has now become clear that IL-13 plays a dominant role in fibrosis [8,9].”
BackgroundCell Signals Influencing Hepatic Fibrosis
Cong, M., Iwaisako, K., Jiang, C., & Kisseleva, T. (2012) · International Journal of Hepatology · doi:10.1155/2012/158547 · Cited by 77
Liu, R., Li, X., Huang, Z., Zhao, D., Sukka-Ganesh, B., Lai, G., Pandak, W. M., Hylemon, P. B., Bajaj, J. S., Sanyal, A. J., et al. (2017) · Hepatology · doi:10.1002/hep.29540 · Cited by 72
The fractalkine receptor CX3CR1 is involved in liver fibrosis due to chronic hepatitis C infection
Wasmuth, H. E., Zaldivar, M. M., Berres, M., Werth, A., Scholten, D., Hillebrandt, S., Tacke, F., Schmitz, P., Dahl, E., Wiederholt, T., et al. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.09.008 · Cited by 70
Pathogenic roles of B lymphocytes in systemic sclerosis
Yoshizaki, A. (2018) · Immunology Letters · doi:10.1016/j.imlet.2018.01.002 · Cited by 79
Metwally, D. M., Al-Olayan, E. M., Alanazi, M. A., Alzahrany, S. B., & Semlali, A. (2018) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-018-2191-z · Cited by 69
Nuocytes and beyond: new insights into helminth expulsion
Neill, D. R., & McKenzie, A. N. J. (2011) · Trends in Parasitology · doi:10.1016/j.pt.2011.01.001 · Cited by 80
The Lung Immune Response to NontypeableHaemophilus influenzae(Lung Immunity to NTHi)
King, P. T., & Sharma, R. (2015) · Journal of Immunology Research · doi:10.1155/2015/706376 · Cited by 77
Adenosine metabolism and murine strain-specific IL-4-induced inflammation, emphysema, and fibrosis
Ma, B., Blackburn, M. R., Lee, C. G., Homer, R. J., Liu, W., Flavell, R. A., Boyden, L., Lifton, R. P., Sun, C.-X., Young, H. W., et al. (2006) · Journal of Clinical Investigation · doi:10.1172/jci26372 · Cited by 72
“…and proteoglycan production in experimental systems (23, 25, 46, 47), and fibroblasts at sites of Th2 inflammation express IL-4R components (48), IL-4 is not thought to be a particularly powerful fibrogenic mediator when compared with other Th2 cytokines, such as IL-13 (18, 20, 26, 27, 29).”
InfluentialLyu, C., Kong, W., Liu, Z., Wang, S., Zhao, P., Liang, K., Niu, Y., Yang, W., Xiang, C., Hu, X., et al. (2023) · Nature Biomedical Engineering · doi:10.1038/s41551-023-01019-z · Cited by 67
Group 2 Innate Lymphoid Cells in the Regulation of Immune Responses
Roediger, B., & Weninger, W. (2014) · Advances in immunology · doi:10.1016/bs.ai.2014.09.004 · Cited by 74
Laplante, P., Brillant-Marquis, F., Brissette, M.-J., Joannette-Pilon, B., Cayrol, R., Kokta, V., & Cailhier, J. (2017) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2017.04.030 · Cited by 68
“M2 macrophages are important in the attenuation of inflammation and the promotion of tissue remodeling (Stout, 2010; Wynn, 2004).”
BackgroundAriyaratne, A., & Finney, C. A. M. (2019) · Infection and Immunity · doi:10.1128/iai.00127-19 · Cited by 74
Omega 3 Fatty Acid and Skin Diseases
Sawada, Y., Saito‐Sasaki, N., & Nakamura, M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.623052 · Cited by 69
“promoting parasite killing (88), tissue repair (89), and immunoregulatory functions (90).”
BackgroundRamos‐Casals, M., Pérez-Álvarez, R., Pérez-De-Lis, M., Xaubet, A., & Bosch, X. (2011) · The American Journal of Medicine · doi:10.1016/j.amjmed.2010.11.028 · Cited by 69
Hecker, M., Zasłona, Z., Kwapiszewska, G., Niess, G., Zakrzewicz, A., Hergenreider, E., Wilhelm, J., Marsh, L. M., Sedding, D., Klepetko, W., et al. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200909-1367oc · Cited by 71
Yamaguchi, T., Takizawa, F., Fischer, U., & Dijkstra, J. M. (2015) · Biology · doi:10.3390/biology4040814 · Cited by 75
Li, G., Larregina, A. T., Domsic, R. T., Stolz, D. B., Medsger, T. A., Lafyatis, R., & Fuschiotti, P. (2016) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2016.11.037 · Cited by 75
“IL-13 is a prominent cytokine participating in the pathogenesis of fibrosis in many diseases (Wynn, 2004).”
Biological Principles of Scar and Contracture
Kwan, P. O., & Tredget, E. E. (2017) · Hand Clinics · doi:10.1016/j.hcl.2016.12.004 · Cited by 75
pDCs in lung and skin fibrosis in a bleomycin-induced model and patients with systemic sclerosis
Kafaja, S., Valera, I., Divekar, A., Saggar, R., Abtin, F. G., Fürst, D. E., Khanna, D., & Singh, R. R. (2018) · JCI Insight · doi:10.1172/jci.insight.98380 · Cited by 75
Interleukin-17: Friend or foe in organ fibrosis
Ramani, K., & Biswas, P. S. (2019) · Cytokine · doi:10.1016/j.cyto.2018.11.003 · Cited by 66
“In contrast, under inflammatory settings where IFN-γ (Th1 cytokine) dominates, organ fibrosis is attenuated [2, 17, 18].”
BackgroundInfluentialIgG4-related disease: a contemporary review
Karadeniz, H., & Vaglio, A. (2020) · TURKISH JOURNAL OF MEDICAL SCIENCES · doi:10.3906/sag-2006-375 · Cited by 70
The Chemokine, CCL3, and Its Receptor, CCR1, Mediate Thoracic Radiation–Induced Pulmonary Fibrosis
Yang, X., Walton, W. G., Cook, D. N., Hua, X., Tilley, S. L., Haskell, C. A., Horuk, R., Blackstock, A. W., & Kirby, S. L. (2010) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2010-0265oc · Cited by 71
A probable role for IFN-γ in the development of a lung immunopathology in SARS
THERON, M., HUANG, K., CHEN, Y., LIU, C., & LEI, H. (2005) · Cytokine · doi:10.1016/j.cyto.2005.07.007 · Cited by 66
“Whilst IFN-g is essentially regarded as an antifibrotic agent, evidence exists to suggest that this cytokine may play an important role in the development of the lung injury that precedes fibrosis [21] .”
BackgroundOrientation fields of nonlinear biological fibrils by second harmonic generation microscopy
Odin, C., Grand, Y. L., Renault, A., Gailhouste, L., & Baffet, G. (2007) · Journal of Microscopy · doi:10.1111/j.1365-2818.2007.01868.x · Cited by 72
“Our method has potential to provide a new high-resolution imaging tool for studying embryogenesis, alignment maps and stress fields in tissues, fibroproliferative diseases (Wynn, 2004, Bataller & Brenner, 2005) and cancer.”
MethodIgG4-Associated Cholangitis: A Comprehensive Review
Hubers, L. M., Wenniger, L. J. M. D. B., Doorenspleet, M. E., Klarenbeek, P. L., Verheij, J., Rauws, E. A., van Gulik, T. M., Elferink, R. P. J. O., van de Graaf, S. F. J., de Vries, N., et al. (2014) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-014-8430-2 · Cited by 67
The Pro-Fibrotic Factor IGFBP-5 Induces Lung Fibroblast and Mononuclear Cell Migration
Yasuoka, H., Yamaguchi, Y., & Feghali‐Bostwick, C. A. (2009) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2008-0211oc · Cited by 70
Conjunctival Transcriptome in Scarring Trachoma
Burton, M. J., Rajak, S. N., Bauer, J., Weiss, H. A., Tolbert, S. B., Shoo, A., Habtamu, E., Manjurano, A. M., Emerson, P. M., Mabey, D. C. W., et al. (2010) · Infection and Immunity · doi:10.1128/iai.00888-10 · Cited by 71
The neonate versus adult mammalian immune system in cardiac repair and regeneration
Sattler, S., & Rosenthal, N. A. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2016.01.011 · Cited by 70
Peng, K., Hsieh, C., Huang, T., Chen, P., Shih, H., Lee, M. S.-S., & Chang, P. (2017) · PLoS ONE · doi:10.1371/journal.pone.0183271 · Cited by 68
Matsuda, M., & Seki, E. (2020) · Food and Chemical Toxicology · doi:10.1016/j.fct.2020.111556 · Cited by 62
Chen, H., Qian, Z., Zhang, S., Tang, J. X., Fang, L., Jiang, F., Ge, D., Chang, J., Cao, J., Yang, L., et al. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101774 · Cited by 75
“2 deaths in developed countries, and significantly reduces the quality of life [12].”
BackgroundImmunomodulation for Tissue Repair and Regeneration
Moon, S., Hong, J., Go, S., & Kim, B. (2023) · Tissue Engineering and Regenerative Medicine · doi:10.1007/s13770-023-00525-0 · Cited by 77
“However, overactivation of these lymphocytes may result in pathogenic fibrosis [28].”
BackgroundTowards a safe and effective chlamydial vaccine: Lessons from the eye
Mabey, D. C. W., Hu, V. H., Bailey, R. L., Burton, M. J., & Holland, M. J. (2014) · Vaccine · doi:10.1016/j.vaccine.2013.10.016 · Cited by 66
Fernández, P., Trzaska, S., Wilder, T., Chiriboga, L. A., Blackburn, M. R., Cronstein, B. N., & Chan, E. S. L. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2008.070952 · Cited by 69
IL-21 Promotes Pulmonary Fibrosis through the Induction of Profibrotic CD8+ T Cells
Brodeur, T. Y., Robidoux, T. E., Weinstein, J. S., Craft, J. E., Swain, S. L., & Marshak‐Rothstein, A. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500777 · Cited by 79
Tryptophan metabolites kynurenine and serotonin regulate fibroblast activation and fibrosis
Dolivo, D., Larson, S. A., & Dominko, T. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2880-2 · Cited by 73
Immune‐Informed Mucin Hydrogels Evade Fibrotic Foreign Body Response In Vivo
Yan, H., Seignez, C., Hjorth, M., Winkeljann, B., Blakeley, M., Lieleg, O., Phillipson, M., & Crouzier, T. (2019) · Advanced Functional Materials · doi:10.1002/adfm.201902581 · Cited by 64
Lakos, G., Melichian, D. S., Wu, M., & Varga, J. (2006) · Pathobiology · doi:10.1159/000098208 · Cited by 69
Famulski, K. S., Sis, B., Billesberger, L., & Halloran, P. F. (2008) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2007.02118.x · Cited by 68
“AMA is also associated with fibrosis, which may play a role in protection against parasites or is necessary for wound repair and tissue remodeling after injury (29).”
BackgroundIkeno, Y., Ohara, D., Takeuchi, Y., Watanabe, H., Kondoh, G., Taura, K., Uemoto, S., & Hirota, K. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.584048 · Cited by 62
“The mediators involved in fibrogenesis are distinct from those involved in inflammation (25).”
BackgroundShi, J., Zhao, J., Zhang, X., Cheng, Y., Hu, J., Li, Y., Zhao, X., Shang, Q., Sun, Y., Tu, B., et al. (2017) · Scientific Reports · doi:10.1038/srep44544 · Cited by 61
Jiao, B., An, C., Du, H., Tran, M., Wang, P., Zhou, D. F., & Wang, Y. (2021) · Cells · doi:10.3390/cells10113057 · Cited by 63
Research progress on drugs targeting the TGF-β signaling pathway in fibrotic diseases
Shi, N., Wang, Z., Zhu, H., Liu, W., Zhao, M., Jiang, X., Zhao, J., Ren, C., Zhang, Y., & Luo, L. (2022) · Immunologic Research · doi:10.1007/s12026-022-09267-y · Cited by 78
Marchioni, A., Tonelli, R., Andreani, A., Cappiello, G. F., Fermi, M., Trentacosti, F., Castaniere, I., Fantini, R., Tabbì, L., Andrisani, D., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052421 · Cited by 74
“They have shown that TH2 response involves IL-4, IL-5 and IL-13 and promotes collagen deposition and ECM remodelling, whereas TH1 responses, together with the production of interferon-γ (IFN-γ), exhibits antifibrotic action [31].”
BackgroundArchie, E. A. (2013) · Parasite Immunology · doi:10.1111/pim.12048 · Cited by 69
Ethanol Consumption Modifies Dendritic Cell Antigen Presentation in Mice
Heinz, R. E., & Waltenbaugh, C. R. (2007) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2007.00479.x · Cited by 69
Immunoregulation of Liver Fibrosis: New Opportunities for Antifibrotic Therapy
(2024) · doi:10.1146/annurev-pharmtox-020524-012013 · Cited by 64
Chirality‐Dependent Reprogramming of Macrophages by Chiral Nanozymes
Zhang, Y., Cui, T., Yang, J., Huang, Y., Ren, J., & Qu, X. (2023) · Angewandte Chemie International Edition · doi:10.1002/anie.202307076 · Cited by 70
Chen, J.-C., Chuang, J.-G., Su, Y.-Y., Chiang, B.-L., Lin, Y.-S., & Chow, L.-P. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.193987 · Cited by 62
Kim, J., Sohn, J.-H., Lee, J., & Park, J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0116540 · Cited by 69
Loss of FOXM1 in macrophages promotes pulmonary fibrosis by activating p38 MAPK signaling pathway
Goda, C., Balli, D., Black, M., Milewski, D., Le, T. T., Ustiyan, V., Ren, X., Kalinichenko, V. V., & Kalin, T. V. (2020) · PLoS Genetics · doi:10.1371/journal.pgen.1008692 · Cited by 66
Eucalyptol prevents bleomycin-induced pulmonary fibrosis and M2 macrophage polarization
Rui, Y., Han, X., Jiang, A., Hu, J., Li, M., Liu, B., Qian, F., & Huang, L. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.175184 · Cited by 61
Pathological collagen targeting and penetrating liposomes for idiopathic pulmonary fibrosis therapy
Yang, M., Lin, Y.-J., Han, M., Bi, Y., He, X.-Y., Xing, L., Jeong, J., Zhou, T., & Jiang, H. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.09.054 · Cited by 63
IL-13RA2 downregulation in fibroblasts promotes keloid fibrosis via JAK/STAT6 activation
Chao, H., Zheng, L., Hsu, P., He, J., Wu, R., Xu, S., Zeng, R., Zhou, Y., Ma, H., Liu, H., et al. (2023) · JCI Insight · doi:10.1172/jci.insight.157091 · Cited by 73
Carvalho, E. M., BASTOS, L. S., & Araújo, M. I. (2006) · Parasite Immunology · doi:10.1111/j.1365-3024.2006.00894.x · Cited by 83
Therapeutic pro-fibrogenic signaling pathways in fibroblasts
Cannito, S., Novo, E., & Parola, M. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.05.017 · Cited by 62
Interactions between macrophages and helminths
Coakley, G., & Harris, N. L. (2020) · Parasite Immunology · doi:10.1111/pim.12717 · Cited by 68
Fibrosis and cancer: shared features and mechanisms suggest common targeted therapeutic approaches
Landolt, L. Z., Spagnoli, G. C., Hertig, A., Brochériou, I., & Marti, H. (2020) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfaa301 · Cited by 63
Gaire, J., Varholick, J. A., Rana, S. D., Sunshine, M. D., Doré, S., Barbazuk, W. B., Fuller, D. D., Maden, M., & Simmons, C. S. (2021) · npj Regenerative Medicine · doi:10.1038/s41536-020-00111-1 · Cited by 62
IL-33/ST2 axis in diverse diseases: regulatory mechanisms and therapeutic potential
Sheng, F., Mi, L., Yu, J.-M., Yang, S., Zou, L., Yang, G., & Zhang, L. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1533335 · Cited by 74
“In patients with chronic liver disease, IL-33 acts as a chemotactic agent for Th2, inducing type 2 polarization of CD4 + T cells, thereby promoting liver fi brosis (104), Th2 cytokines, such as IL-6, IL-4, and IL-13, promoting the formation of fi brosis (105).”
Role of resident liver cells in the pathogenesis of schistosomiasis
Anthony, B. J., Ramm, G. A., & McManus, D. P. (2012) · Trends in Parasitology · doi:10.1016/j.pt.2012.09.005 · Cited by 60
Modelling and targeting mechanical forces in organ fibrosis
Mascharak, S., L. Guo, J., Griffin, M., E. Berry, C., C. Wan, D., & T. Longaker, M. (2024) · Nature Reviews Bioengineering · doi:10.1038/s44222-023-00144-3 · Cited by 59
Gunaydin, G., Kesikli, S. A., & Guc, D. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1034918 · Cited by 59
Biology of Chronic Graft-versus-Host Disease: Implications for a Future Therapeutic Approach
Martin, P. J. (2008) · The Keio Journal of Medicine · doi:10.2302/kjm.57.177 · Cited by 59
Metadata
- Authors
- Wynn, T. A.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Wynn, Thomas A.
- ORCID
- Wynn, Thomas A.
- Venue
- Nature Reviews Immunology
- Published
- 2004-08
- Volume
- 4
- Issue
- 8
- Pages
- 583-594
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- PMC
- PMC2702150
- OpenAlex
- W1983357763
- Cited by
- 1,765
- References
- 135
- Citations by year
- 2026: 46 · 2025: 76 · 2024: 93 · 2023: 104 · 2022: 126 · 2021: 96 · 2020: 99 · 2019: 83 · 2018: 91 · 2017: 95 · 2016: 87 · 2015: 91 · 2014: 94 · 2013: 82 · 2012: 75
- FWCI
- 8.75
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases (Z01AI001019, Z01AI000829)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- fibrosis, fibrogenesis, Th1/Th2 paradigm, T helper cells, idiopathic pulmonary fibrosis, liver fibrosis, systemic sclerosis, wound healing, fibroproliferative disorders
- MeSH terms
- Animals, Fibroblasts, Fibrosis, Humans, Macrophages, Transforming Growth Factor beta, Th1 Cells, Th2 Cells, Interleukin-13, Chemokines
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.